Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Global X Genomics & Biotechnology ETF
(NASDAQ:GNOM)
Intraday
$9.92
0.1395
[1.43%]
After-Hours
$9.92
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$9.92
0.1395
[1.43%]
At close: Apr 19
$9.92
0
[0.00%]
After Hours: 5:42PM EDT
Get Report
Watch
Overview
News
Dividends
Short Interest
Latest News for Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)
Global X Genomics & Biotechnology ETF (NASDAQ: GNOM)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 05, 2020
68 Stocks Trading Near 52-Week Highs Just After Open On Thursday, Nov. 5, 2020:
Benzinga Newsdesk
-
Nov 5, 2020, 9:52AM
Tuesday, May 26, 2020
3 Genomics ETFs Worth Jumping For
ETF Professor
-
May 26, 2020, 12:50PM
Thursday, October 10, 2019
This High Growth ETF May Not Be As Pricey As You Think
ETF Professor
-
Oct 10, 2019, 9:25AM
Wednesday, April 10, 2019
Get In On Genomics With This New ETF
ETF Professor
-
Apr 10, 2019, 8:01AM
Wednesday, March 13, 2013
Benzinga Market Primer: Wednesday, March 13
Benzinga
-
Mar 13, 2013, 6:31AM
Monday, February 25, 2013
BGI-Shenzhen Receives Approval from Ministry of Commerce of PRC for Proposed Acquisition Of Complete Genomics
Benzinga
-
Feb 25, 2013, 10:12PM
Saturday, February 23, 2013
Benzinga's M&A Chatter for Friday February 22, 2013
Benzinga
-
Feb 23, 2013, 10:53AM
Friday, February 22, 2013
BGI-Shenzhen Extends Tender Offer for Complete Genomics to Friday, February 22, 2013
Benzinga
-
Feb 22, 2013, 9:51PM
Thursday, February 07, 2013
BGI-Shenzhen Extends Tender Offer For Complete Genomics to Friday, February 22, 2013
Benzinga
-
Feb 7, 2013, 5:56AM
Friday, January 25, 2013
BGI-Shenzhen Extends Tender Offer for Complete Genomics
Benzinga
-
Jan 25, 2013, 8:30PM
Saturday, January 12, 2013
BGI-Shenzhen and Complete Genomics Receive Clearance from China Regulatory Agency for Merger
Benzinga
-
Jan 12, 2013, 7:57AM
BGI-Shenzhen Announces an Additional Extension of Tender Offer for Complete Genomics
Benzinga
-
Jan 12, 2013, 7:54AM
Tuesday, January 08, 2013
Benzinga's M&A Chatter for Tuesday January 8, 2013
Benzinga
-
Jan 8, 2013, 8:07PM
Illumina Withdraws Offer to Buy Complete Genomics
Benzinga
-
Jan 8, 2013, 11:39AM
Monday, January 07, 2013
BGI-Shenzhen Extends All-Cash Tender Offer for Complete Genomics to January 11, 2013
Benzinga
-
Jan 7, 2013, 7:16AM
Saturday, December 29, 2012
BGI-Shenzhen Extends All-Cash Tender Offer for Complete Genomics
Benzinga
-
Dec 29, 2012, 8:09AM
BGI-Shenzhen Receives CFIUS Clearance for Proposed Acquisition of Complete Genomics
Benzinga
-
Dec 29, 2012, 8:07AM
Thursday, December 13, 2012
BGI-Shenzhen Announces Extension of Tender Offer For Complete Genomics
Benzinga
-
Dec 13, 2012, 10:25PM
Thursday, November 22, 2012
Benzinga's M&A Chatter for Wednesday November 21, 2012
Benzinga
-
Nov 22, 2012, 12:06PM
Wednesday, November 21, 2012
Illumina Sends Letter to Complete Genomics Board, Expecting No Antitrust Issues with Bid
Benzinga
-
Nov 21, 2012, 8:59AM
Tuesday, November 20, 2012
BGI-Shenzhen Extends Tender Offer For Complete Genomics to December 14, 2012
Benzinga
-
Nov 20, 2012, 9:47PM
Friday, November 16, 2012
Illumina Confirms It is 'Party H' in Complete Genomics Filing
Benzinga
-
Nov 16, 2012, 4:21PM
Tuesday, November 13, 2012
Complete Genomics Received $3.30/Share Bid from Party H on Nov. 5th, Says Did Not Constitute Superior Proposal
Benzinga
-
Nov 13, 2012, 8:56AM
Wednesday, October 24, 2012
FDA Considering Faster Approval Process for Developers of Drugs for Deadly or Debilitating Diseases
Benzinga
-
Oct 24, 2012, 8:23AM
Monday, October 22, 2012
BGI-Shenzhen Extends Tender Offer For Complete Genomics Shares
Benzinga
-
Oct 22, 2012, 9:52PM
Thursday, October 18, 2012
Complete Genomics Reports Favorable Ruling in Patent Suit Against Illumina
Benzinga
-
Oct 18, 2012, 6:59AM
Thursday, September 27, 2012
Knome Taking Orders for knoSYS™100
Benzinga
-
Sep 27, 2012, 7:22AM
Monday, September 17, 2012
Benzinga's M&A Chatter for Monday September 17, 2012
Benzinga
-
Sep 17, 2012, 7:04PM
Morning Market Movers
Benzinga
-
Sep 17, 2012, 9:49AM
Benzinga's Top Pre-Market Gainers
Benzinga
-
Sep 17, 2012, 8:14AM
A Peek Into The Market Before The Trading Starts
Benzinga
-
Sep 17, 2012, 7:17AM
Complete Genomics Will be Acquired by Shenzhen; Holders Will Get $3.15
Benzinga
-
Sep 17, 2012, 6:43AM
Tuesday, September 11, 2012
Baird Downgrades Complete Genomics to Neutral, PT to $3
Benzinga
-
Sep 11, 2012, 9:15AM
Friday, August 31, 2012
Watchlist for Friday, Aug 31
Benzinga
-
Aug 31, 2012, 9:44AM
Thursday, August 30, 2012
Hearing Chatter in Complete Genomics
Benzinga
-
Aug 30, 2012, 3:22PM
Complete Genomics Spikes to High, $3.09
Benzinga
-
Aug 30, 2012, 3:12PM
Thursday, August 09, 2012
Benzinga's Microcap Movers for Thursday August 9, 2012
Benzinga
-
Aug 9, 2012, 8:13PM
Benzinga's M&A Chatter for Thursday August 9, 2012
Benzinga
-
Aug 9, 2012, 5:47PM
Complete Genomics Cancels Conference Call
Benzinga
-
Aug 9, 2012, 9:20AM
Friday, July 27, 2012
Social Media Outlook for Friday July 27 (NYT, XNPT, GDOT, STRA)
Benzinga
-
Jul 27, 2012, 3:02PM
Wednesday, July 25, 2012
Benzinga's M&A Chatter for Wednesday July 25, 2012
Benzinga
-
Jul 25, 2012, 5:09PM
Complete Genomics Spiking Higher on Takeover Chatter
Benzinga
-
Jul 25, 2012, 9:51AM
Complete Genomics Spiking Higher on Takeover Chatter
Benzinga
-
Jul 25, 2012, 9:51AM
Monday, July 23, 2012
Complete Genomics Spiking Higher
Benzinga
-
Jul 23, 2012, 12:30PM
Monday, July 16, 2012
McNicoll Lewis Vlak Suspends Coverage on Complete Genomics
Benzinga
-
Jul 16, 2012, 7:00AM
Friday, July 13, 2012
Social Media Outlook, Friday July 13
Benzinga
-
Jul 13, 2012, 12:24PM
Thursday, July 12, 2012
Complete Genomics Rises 15% Pre-Market
Benzinga
-
Jul 12, 2012, 8:22AM
Benzinga's Top Pre-Market Gainers
Benzinga
-
Jul 12, 2012, 8:13AM
Wednesday, July 11, 2012
Complete Genomics Pops 30% on New Technology Development
Benzinga
-
Jul 11, 2012, 2:38PM
Complete Genomics Announces New Technology Developed to Set Standard for Clinical-Grade Genomes
Benzinga
-
Jul 11, 2012, 1:06PM
Show more